Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Anderson

Showing results (201-210 of 271) with videos related to

Pageof 28
Sort By:
Plos Medicine|May 8, 2024
Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohortMark A M van den Elshout, Eline S Wijstma, Anders Boyd, et al.
Plos One|August 21, 2019
Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil StudyLuana M S Marins, Thiago S Torres, Iuri da C Leite, et al.
AIDS (London, England)|June 8, 2023
HIV pre-exposure prophylaxis initiation, persistence, and adherence during pregnancy through the postpartum periodJillian Pintye, John Kinuthia, Felix Abuna, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2019
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarateKristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent DosingJose Castillo-Mancilla, Sharon Seifert, Kayla Campbell, et al.
AIDS and Behavior|May 26, 2026
A Narrative Review of Remote Biospecimen Collection Product and Implementation Considerations for Sexual Health Clinical ResearchKeith J Horvath, Sarah E Rutstein, Ryan P Coyle, et al.
AIDS (London, England)|June 13, 2018
Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxisMaria Pyra, Peter L Anderson, Craig W Hendrix, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2022
Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol useKristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2016
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)Jose R Castillo-Mancilla, Christina L Aquilante, Michael F Wempe, et al.
The Journal of Antimicrobial Chemotherapy|January 12, 2017
Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trialJulien Fonsart, Sentob Saragosti, Milad Taouk, et al.
Pageof 28

Showing results (201-210 of 271) with videos related to

Sort By:
Pageof 28
Plos Medicine|May 8, 2024
Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohortMark A M van den Elshout, Eline S Wijstma, Anders Boyd, et al.
Plos One|August 21, 2019
Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil StudyLuana M S Marins, Thiago S Torres, Iuri da C Leite, et al.
AIDS (London, England)|June 8, 2023
HIV pre-exposure prophylaxis initiation, persistence, and adherence during pregnancy through the postpartum periodJillian Pintye, John Kinuthia, Felix Abuna, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2019
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarateKristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent DosingJose Castillo-Mancilla, Sharon Seifert, Kayla Campbell, et al.
AIDS and Behavior|May 26, 2026
A Narrative Review of Remote Biospecimen Collection Product and Implementation Considerations for Sexual Health Clinical ResearchKeith J Horvath, Sarah E Rutstein, Ryan P Coyle, et al.
AIDS (London, England)|June 13, 2018
Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxisMaria Pyra, Peter L Anderson, Craig W Hendrix, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2022
Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol useKristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2016
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)Jose R Castillo-Mancilla, Christina L Aquilante, Michael F Wempe, et al.
The Journal of Antimicrobial Chemotherapy|January 12, 2017
Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trialJulien Fonsart, Sentob Saragosti, Milad Taouk, et al.
Pageof 28